Comparison of toxicity profile and tolerability between two standard of care paclitaxel-based adjuvant chemotherapy regimens in breast cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2016-02-16

AUTHORS

Mohamed Alsharedi, Todd Gress, Jennifer Dotson, Nabiha Elmsherghi, Maria Tria Tirona

ABSTRACT

In breast cancer, there are two widely used paclitaxel-based adjuvant chemotherapies, either dose dense paclitaxel (ddP) or weekly paclitaxel (wP). To our knowledge, the comparisons of toxicity and tolerability between the two regimens have never been reported in the literature. This is a retrospective single-institution charts review of breast cancer patients who were treated with paclitaxel-based chemotherapy either ddP or wP. In total, 76 and 45 patients with breast cancer received adjuvant standard ddP and wP, respectively. Patient characteristics in both groups were comparable. Our results showed no statistical significant difference in toxicity profile and tolerability between the two regimens. Particularly, chemotherapy-induced peripheral neuropathy (CIPN) was equally observed in both schedules. Furthermore, grade 3 and 4 CIPN was observed in 17 and 18 %, respectively (p = 0.93). In terms of tolerability, both regimens resulted in similar rates of hospitalization and treatment discontinuation. Our data analysis indicates no significant difference in toxicity profile between the two standard paclitaxel regimens in breast cancer. However, this is a small sample-sized retrospective study and further prospective trial with a larger sample size is warranted. More... »

PAGES

27

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12032-016-0740-1

DOI

http://dx.doi.org/10.1007/s12032-016-0740-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1006329883

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/26883934


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Phytogenic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemotherapy, Adjuvant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neutropenia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Paclitaxel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Retrospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Standard of Care", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA", 
          "id": "http://www.grid.ac/institutes/grid.259676.9", 
          "name": [
            "Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Alsharedi", 
        "givenName": "Mohamed", 
        "id": "sg:person.01037220762.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037220762.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA", 
          "id": "http://www.grid.ac/institutes/grid.259676.9", 
          "name": [
            "Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gress", 
        "givenName": "Todd", 
        "id": "sg:person.01361322147.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361322147.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA", 
          "id": "http://www.grid.ac/institutes/grid.259676.9", 
          "name": [
            "Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dotson", 
        "givenName": "Jennifer", 
        "id": "sg:person.01362136207.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362136207.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA", 
          "id": "http://www.grid.ac/institutes/grid.259676.9", 
          "name": [
            "Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Elmsherghi", 
        "givenName": "Nabiha", 
        "id": "sg:person.01152410333.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152410333.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA", 
          "id": "http://www.grid.ac/institutes/grid.259676.9", 
          "name": [
            "Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tirona", 
        "givenName": "Maria Tria", 
        "id": "sg:person.010157155137.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010157155137.60"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s10549-008-0152-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030328941", 
          "https://doi.org/10.1007/s10549-008-0152-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-014-2255-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016775495", 
          "https://doi.org/10.1007/s00520-014-2255-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-13-240", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003190434", 
          "https://doi.org/10.1186/1471-2407-13-240"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10147-011-0352-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039382949", 
          "https://doi.org/10.1007/s10147-011-0352-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-014-2607-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041788748", 
          "https://doi.org/10.1007/s00280-014-2607-5"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2016-02-16", 
    "datePublishedReg": "2016-02-16", 
    "description": "Abstract\nIn breast cancer, there are two widely used paclitaxel-based adjuvant chemotherapies, either dose dense paclitaxel (ddP) or weekly paclitaxel (wP). To our knowledge, the comparisons of toxicity and tolerability between the two regimens have never been reported in the literature. This is a retrospective single-institution charts review of breast cancer patients who were treated with paclitaxel-based chemotherapy either ddP or wP. In total, 76 and 45 patients with breast cancer received adjuvant standard ddP and wP, respectively. Patient characteristics in both groups were comparable. Our results showed no statistical significant difference in toxicity profile and tolerability between the two regimens. Particularly, chemotherapy-induced peripheral neuropathy (CIPN) was equally observed in both schedules. Furthermore, grade 3 and 4 CIPN was observed in 17 and 18\u00a0%, respectively (p\u00a0=\u00a00.93). In terms of tolerability, both regimens resulted in similar rates of hospitalization and treatment discontinuation. Our data analysis indicates no significant difference in toxicity profile between the two standard paclitaxel regimens in breast cancer. However, this is a small sample-sized retrospective study and further prospective trial with a larger sample size is warranted.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s12032-016-0740-1", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094524", 
        "issn": [
          "1357-0560", 
          "1559-131X"
        ], 
        "name": "Medical Oncology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "keywords": [
      "chemotherapy-induced peripheral neuropathy", 
      "breast cancer", 
      "toxicity profile", 
      "adjuvant chemotherapy", 
      "retrospective single-institution chart review", 
      "single-institution chart review", 
      "Further prospective trials", 
      "terms of tolerability", 
      "paclitaxel-based chemotherapy", 
      "breast cancer patients", 
      "significant differences", 
      "statistical significant difference", 
      "weekly paclitaxel", 
      "paclitaxel regimens", 
      "treatment discontinuation", 
      "chart review", 
      "prospective trial", 
      "patient characteristics", 
      "peripheral neuropathy", 
      "retrospective study", 
      "cancer patients", 
      "grade 3", 
      "tolerability", 
      "regimens", 
      "larger sample size", 
      "chemotherapy", 
      "cancer", 
      "Comparison of toxicity", 
      "patients", 
      "similar rates", 
      "paclitaxel", 
      "DDP", 
      "sample size", 
      "neuropathy", 
      "hospitalization", 
      "discontinuation", 
      "trials", 
      "differences", 
      "toxicity", 
      "profile", 
      "review", 
      "group", 
      "data analysis", 
      "schedule", 
      "study", 
      "rate", 
      "comparison", 
      "literature", 
      "knowledge", 
      "standards", 
      "analysis", 
      "results", 
      "characteristics", 
      "size", 
      "terms"
    ], 
    "name": "Comparison of toxicity profile and tolerability between two standard of care paclitaxel-based adjuvant chemotherapy regimens in breast cancer", 
    "pagination": "27", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1006329883"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12032-016-0740-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "26883934"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12032-016-0740-1", 
      "https://app.dimensions.ai/details/publication/pub.1006329883"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T21:01", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_693.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s12032-016-0740-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12032-016-0740-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12032-016-0740-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12032-016-0740-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12032-016-0740-1'


 

This table displays all metadata directly associated to this object as RDF triples.

208 TRIPLES      21 PREDICATES      96 URIs      83 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12032-016-0740-1 schema:about N020ff17e63e44ad29a24c1258cbe1b25
2 N0813865930454e448d612dcbdb949855
3 N0f0a98cd3899497f998ba6780e2758ca
4 N172f9114c2884e2fbf2722a1e453c589
5 N1778447299cf497db3ac1bdedb781664
6 N2680a7f497a741279ea41c88e0d0077d
7 N58edf9ec198f4ace8d8b30dc1908fd5c
8 N5cb14ef988614f289babbaaff3388d36
9 N75ede88d02cb499fa8be63d6b585bab3
10 N83376d02d27f4980bdc5e8581480c024
11 Naff41b689950451c9da11f975bd927a4
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author Ncf4ec1d8910c4df5b1a0651040072de4
15 schema:citation sg:pub.10.1007/s00280-014-2607-5
16 sg:pub.10.1007/s00520-014-2255-7
17 sg:pub.10.1007/s10147-011-0352-x
18 sg:pub.10.1007/s10549-008-0152-9
19 sg:pub.10.1186/1471-2407-13-240
20 schema:datePublished 2016-02-16
21 schema:datePublishedReg 2016-02-16
22 schema:description Abstract In breast cancer, there are two widely used paclitaxel-based adjuvant chemotherapies, either dose dense paclitaxel (ddP) or weekly paclitaxel (wP). To our knowledge, the comparisons of toxicity and tolerability between the two regimens have never been reported in the literature. This is a retrospective single-institution charts review of breast cancer patients who were treated with paclitaxel-based chemotherapy either ddP or wP. In total, 76 and 45 patients with breast cancer received adjuvant standard ddP and wP, respectively. Patient characteristics in both groups were comparable. Our results showed no statistical significant difference in toxicity profile and tolerability between the two regimens. Particularly, chemotherapy-induced peripheral neuropathy (CIPN) was equally observed in both schedules. Furthermore, grade 3 and 4 CIPN was observed in 17 and 18 %, respectively (p = 0.93). In terms of tolerability, both regimens resulted in similar rates of hospitalization and treatment discontinuation. Our data analysis indicates no significant difference in toxicity profile between the two standard paclitaxel regimens in breast cancer. However, this is a small sample-sized retrospective study and further prospective trial with a larger sample size is warranted.
23 schema:genre article
24 schema:isAccessibleForFree false
25 schema:isPartOf N48171a5cca82498989463cbb23ad3505
26 Nc94d6d874f7d463a8c3aefd429118469
27 sg:journal.1094524
28 schema:keywords Comparison of toxicity
29 DDP
30 Further prospective trials
31 adjuvant chemotherapy
32 analysis
33 breast cancer
34 breast cancer patients
35 cancer
36 cancer patients
37 characteristics
38 chart review
39 chemotherapy
40 chemotherapy-induced peripheral neuropathy
41 comparison
42 data analysis
43 differences
44 discontinuation
45 grade 3
46 group
47 hospitalization
48 knowledge
49 larger sample size
50 literature
51 neuropathy
52 paclitaxel
53 paclitaxel regimens
54 paclitaxel-based chemotherapy
55 patient characteristics
56 patients
57 peripheral neuropathy
58 profile
59 prospective trial
60 rate
61 regimens
62 results
63 retrospective single-institution chart review
64 retrospective study
65 review
66 sample size
67 schedule
68 significant differences
69 similar rates
70 single-institution chart review
71 size
72 standards
73 statistical significant difference
74 study
75 terms
76 terms of tolerability
77 tolerability
78 toxicity
79 toxicity profile
80 treatment discontinuation
81 trials
82 weekly paclitaxel
83 schema:name Comparison of toxicity profile and tolerability between two standard of care paclitaxel-based adjuvant chemotherapy regimens in breast cancer
84 schema:pagination 27
85 schema:productId N3ff698d8fead400293938f9374c55aa2
86 Nc487162fca5443849dc5e798bbb8ae00
87 Nf314fa308fbd42b8942dd9ae794a827f
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006329883
89 https://doi.org/10.1007/s12032-016-0740-1
90 schema:sdDatePublished 2022-11-24T21:01
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher N94e351aed3ea4a6b81aca4f6829c1840
93 schema:url https://doi.org/10.1007/s12032-016-0740-1
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N020ff17e63e44ad29a24c1258cbe1b25 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Humans
99 rdf:type schema:DefinedTerm
100 N0813865930454e448d612dcbdb949855 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
101 schema:name Chemotherapy, Adjuvant
102 rdf:type schema:DefinedTerm
103 N0df91e42de0d45198230edbe42845248 rdf:first sg:person.01361322147.40
104 rdf:rest N86bc8a4fdce04e29953a76dd5cc1943f
105 N0f0a98cd3899497f998ba6780e2758ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Female
107 rdf:type schema:DefinedTerm
108 N172f9114c2884e2fbf2722a1e453c589 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Antineoplastic Agents, Phytogenic
110 rdf:type schema:DefinedTerm
111 N1778447299cf497db3ac1bdedb781664 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Breast Neoplasms
113 rdf:type schema:DefinedTerm
114 N2680a7f497a741279ea41c88e0d0077d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Standard of Care
116 rdf:type schema:DefinedTerm
117 N3ff698d8fead400293938f9374c55aa2 schema:name pubmed_id
118 schema:value 26883934
119 rdf:type schema:PropertyValue
120 N48171a5cca82498989463cbb23ad3505 schema:issueNumber 3
121 rdf:type schema:PublicationIssue
122 N58edf9ec198f4ace8d8b30dc1908fd5c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Retrospective Studies
124 rdf:type schema:DefinedTerm
125 N5cb14ef988614f289babbaaff3388d36 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Middle Aged
127 rdf:type schema:DefinedTerm
128 N75ede88d02cb499fa8be63d6b585bab3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Antineoplastic Combined Chemotherapy Protocols
130 rdf:type schema:DefinedTerm
131 N83376d02d27f4980bdc5e8581480c024 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Paclitaxel
133 rdf:type schema:DefinedTerm
134 N86bc8a4fdce04e29953a76dd5cc1943f rdf:first sg:person.01362136207.47
135 rdf:rest Nd295b4d2939f4ee8b2304f37aa0574d3
136 N94e351aed3ea4a6b81aca4f6829c1840 schema:name Springer Nature - SN SciGraph project
137 rdf:type schema:Organization
138 Naff41b689950451c9da11f975bd927a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Neutropenia
140 rdf:type schema:DefinedTerm
141 Nc487162fca5443849dc5e798bbb8ae00 schema:name dimensions_id
142 schema:value pub.1006329883
143 rdf:type schema:PropertyValue
144 Nc94d6d874f7d463a8c3aefd429118469 schema:volumeNumber 33
145 rdf:type schema:PublicationVolume
146 Ncf4ec1d8910c4df5b1a0651040072de4 rdf:first sg:person.01037220762.97
147 rdf:rest N0df91e42de0d45198230edbe42845248
148 Nd295b4d2939f4ee8b2304f37aa0574d3 rdf:first sg:person.01152410333.55
149 rdf:rest Ndf8dc107af6b4427942533d667298d5e
150 Ndf8dc107af6b4427942533d667298d5e rdf:first sg:person.010157155137.60
151 rdf:rest rdf:nil
152 Nf314fa308fbd42b8942dd9ae794a827f schema:name doi
153 schema:value 10.1007/s12032-016-0740-1
154 rdf:type schema:PropertyValue
155 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
156 schema:name Medical and Health Sciences
157 rdf:type schema:DefinedTerm
158 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
159 schema:name Oncology and Carcinogenesis
160 rdf:type schema:DefinedTerm
161 sg:journal.1094524 schema:issn 1357-0560
162 1559-131X
163 schema:name Medical Oncology
164 schema:publisher Springer Nature
165 rdf:type schema:Periodical
166 sg:person.010157155137.60 schema:affiliation grid-institutes:grid.259676.9
167 schema:familyName Tirona
168 schema:givenName Maria Tria
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010157155137.60
170 rdf:type schema:Person
171 sg:person.01037220762.97 schema:affiliation grid-institutes:grid.259676.9
172 schema:familyName Alsharedi
173 schema:givenName Mohamed
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01037220762.97
175 rdf:type schema:Person
176 sg:person.01152410333.55 schema:affiliation grid-institutes:grid.259676.9
177 schema:familyName Elmsherghi
178 schema:givenName Nabiha
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01152410333.55
180 rdf:type schema:Person
181 sg:person.01361322147.40 schema:affiliation grid-institutes:grid.259676.9
182 schema:familyName Gress
183 schema:givenName Todd
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01361322147.40
185 rdf:type schema:Person
186 sg:person.01362136207.47 schema:affiliation grid-institutes:grid.259676.9
187 schema:familyName Dotson
188 schema:givenName Jennifer
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01362136207.47
190 rdf:type schema:Person
191 sg:pub.10.1007/s00280-014-2607-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041788748
192 https://doi.org/10.1007/s00280-014-2607-5
193 rdf:type schema:CreativeWork
194 sg:pub.10.1007/s00520-014-2255-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016775495
195 https://doi.org/10.1007/s00520-014-2255-7
196 rdf:type schema:CreativeWork
197 sg:pub.10.1007/s10147-011-0352-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1039382949
198 https://doi.org/10.1007/s10147-011-0352-x
199 rdf:type schema:CreativeWork
200 sg:pub.10.1007/s10549-008-0152-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030328941
201 https://doi.org/10.1007/s10549-008-0152-9
202 rdf:type schema:CreativeWork
203 sg:pub.10.1186/1471-2407-13-240 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003190434
204 https://doi.org/10.1186/1471-2407-13-240
205 rdf:type schema:CreativeWork
206 grid-institutes:grid.259676.9 schema:alternateName Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA
207 schema:name Division of Hematology and Oncology, Edwards Comprehensive Cancer Center at Cabell Huntington Hospital, Joan C. Edwards School of Medicine, Marshall University, 1400 Hal Greer Blvd., 25701, Huntington, WV, USA
208 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...